First-cycle CSRD pass with every factor traceable to a named source — a 4,500-employee specialty pharma group.
Pharma buyers are bought on audit defensibility, not feature breadth. The operator profiled below required that every emission factor in its disclosure resolve to a documented source — and that the methodology survive a third-party limited assurance review without restatement.
Book a live demo→
P-01
Every emission factor traceable to a named, auditable source
The platform's methodology page links each factor to its origin dataset. The pharma group's external assurance provider confirmed traceability across 100% of the disclosure boundary.
100% factor traceability
P-02
First-cycle CSRD pass rate held across the disclosure boundary
Scope 1, 2 and the material Scope 3 categories were disclosed on the first audit cycle — consistent with the 94% platform-wide first-cycle pass rate.
First-cycle pass · zero restatements
P-03
Validated methodology reduced assurance provider review time
Limited assurance review was completed in 4 weeks instead of the customer's prior 11-week benchmark. The Fraunhofer ISI methodology audit was referenced in the assurance opinion.
−63% assurance review time